Skip to content
Aldeyra logo
  • Contact Us
  • Contact Us
  • Patients & Caregivers
    • Dry Eye Disease Symptoms & Treatment
    • Allergic Conjunctivitis Symptoms & Treatment
    • Proliferative Vitreoretinopathy Symptoms & Treatment
    • Early Access Program
    • Clinical Trials
  • Science & Technology
    • Reactive Aldehyde Species Inhibition
    • Dihydrofolate Reductase Inhibition
    • Posters & Publications
  • Pipeline & Disease Areas
    • Ocular and Inflammatory Diseases
      • Dry Eye Disease
      • Allergic Conjunctivitis
      • Proliferative Vitreoretinopathy
  • Investors & Media
    • Overview
    • Corporate Governance
      • Charters & Governance
      • Leadership Team & Board of Directors
      • Committee Composition
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Stock Information
    • SEC Filings
    • Investor FAQs
    • Investor Email Alerts
  • About
    • Corporate Overview
    • Leadership Team & Board of Directors
  • Careers

Posters and Presentations

Posters and Presentations
Poster Presentation – The Novel RASP Modulator Reproxalap Rapidly Improves Signs and Symptoms of Dry Eye Disease: The TRANQUILITY Run In Cohort
  • PDF (233.50 KB)

April 2022

Read More
Posters and Presentations
Poster Presentation – A Phase 2 Clinical Trial of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in an Allergen Chamber Model of Allergic Conjunctivitis (American Academy of Ophthalmology 2020 Annual Meeting)
  • PDF (802.22 KB)

November 2020

Read More
Posters and Presentations
Poster Presentation of ALLEVIATE Phase 3 Allergic Conjunctivitis Clinical Trial of Topical Ocular Reproxalap (American Academy of Ophthalmology 2019 Annual Meeting)
  • PDF (649.05 KB)

October 2019

Read More
Posters and Presentations
Podium Presentation of Dry Eye Disease 2b Clinical Trial of Reproxalap (2019 ARVO Annual Meeting) – May 2019
  • PDF (2.47 MB)

May 2019

Read More
Posters and Presentations
Poster Presentation of ADX-103 Activity in Model of Diabetic Macular Edema (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018
  • PDF (241.60 KB)

May 2018

Read More
Posters and Presentations
Poster Presentation of Allergic Conjunctivitis Phase 2b Clinical Trial of Reproxalap (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018
  • PDF (238.67 KB)

May 2018

Read More
Posters and Presentations
Poster Presentation of Reproxalap and ADX-103 Activity in Models of Pan-Ocular and Retinal Diseases (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – May 2018
  • PDF (633.49 KB)

May 2018

Read More
Posters and Presentations
Podium Presentation of Phase 2a Dry Eye Disease Clinical Trial Results (Association for Research in Vision and Ophthalmology 2018 Annual Meeting) – April 2018
  • PDF (724.63 KB)

April 2018

Read More
Posters and Presentations
Podium Presentation of Statistical Non-inferiority of Reproxalap to Corticosteroid Therapy in Noninfectious Anterior Uveitis (2017 American Uveitis Society Fall Meeting) – November 2017
  • PDF (599.41 KB)

November 2017

Read More
Posters and Presentations
Poster Presentation of Reproxalap Activity in Model of Succinic Semi-Aldehyde Dehydrogenase Deficiency (American Society of Human Genetics 2017 Annual Meeting) – October 2017
  • PDF (703.87 KB)

October 2017

Read More
1 2 3 Next
  • Facebook
  • LinkedIn
  • Privacy Policy
  • Terms of Service
  • Sitemap
© Aldeyra Therapeutics, Inc., 2023. All Rights Reserved.